PMED-1 is a beta-catenin inhibitor that significantly reduces beta-catenin activity in hepatoblastoma cells and various HCC cells, with an IC50 value ranging from 4.87 to 32 µM. PMED-1 affects Wnt signaling by decreasing the interaction between beta-catenin and CREB binding protein, thereby inhibiting cell proliferation. PMED-1 has potential applications in cancer research[1].
Molekulargewicht:
335.37
CAS Nummer:
[491828-75-2]
Formel:
C20H18FN3O
Target-Kategorie:
Wnt
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
